Literature DB >> 12174770

Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa.

Anna M Molesworth1, Madeleine C Thomson, Stephen J Connor, Mark P Cresswell, Andrew P Morse, Paul Shears, C Anthony Hart, Luis E Cuevas.   

Abstract

Mapping an area at risk of epidemics of meningococcal meningitis in Africa has significant implications for their prevention and case treatment, through the targeted development of improved surveillance systems and control policies. Such an area was described using information obtained from published and unpublished reports of meningitis epidemics between 1980 and 1999 and cases of meningococcal disease reported by surveillance systems to WHO. The Sahel bore the greatest epidemic burden, with over two-thirds of documented outbreaks and high attack rates. In addition to those already in the Meningitis Belt, countries affected included Guinea-Bissau, Guinea, Côte d'Ivoire, Togo, the Central African Republic and Eritrea. Elsewhere epidemics were reported from a band of countries around the Rift Valley and Great Lakes regions extending as far south as Mozambique and from here west to Angola and Namibia in southern Africa. The cumulative pan-continental analysis provided evidence of an epidemic-susceptible area which extends beyond the region accepted as the Meningitis Belt and which, moreover, may be partially determined by the physical environment, as shown by a striking correspondence to the 300-1100-mm mean annual rainfall isohyets.

Entities:  

Mesh:

Year:  2002        PMID: 12174770     DOI: 10.1016/s0035-9203(02)90089-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  52 in total

Review 1.  Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.

Authors:  Idris Mohammed; Garba Iliyasu; Abdulrazaq Garba Habib
Journal:  Pathog Glob Health       Date:  2017-01-12       Impact factor: 2.894

Review 2.  Meningococcal disease and its management in children.

Authors:  C Anthony Hart; Alistair P J Thomson
Journal:  BMJ       Date:  2006-09-30

3.  Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Authors:  Christopher B Nelson; Maureen Birmingham; Alejandro Costa; Joelle Daviaud; William Perea; Marie-Paule Kieny; Daniel Tarantola
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

4.  African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults.

Authors:  Bradford D Gessner; Judith E Mueller; Seydou Yaro
Journal:  BMC Infect Dis       Date:  2010-02-10       Impact factor: 3.090

5.  Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

Authors:  Danny Altmann; Abraham Aseffa; Margaret Bash; Nicole Basta; Ray Borrow; Claire Broome; Dominique Caugant; Tom Clark; Jean-Marc Collard; Mamoudou Djingarey; David Goldblatt; Brian Greenwood; Ulla Griffiths; Rana Hajjeh; Musa Hassan-King; Stephane Hugonnet; Ann Marie Kimball; Marc LaForce; Calman MacLennan; Martin C J Maiden; Olivier Manigart; Leonard Mayer; Nancy Messonnier; Jennifer Moisi; Katie Moore; Daugla Doumagoum Moto; Judith Mueller; Maria Nascimento; Stephen Obaro; Rasmata Ouedraogo; Anne-Laure Page; Willima Perea; Gerd Pluschke; Mari-Pierre Preziosi; Samba Sow; David Stephens; James Stuart; Madeleiene Thomson; Sylvestre Tiendrebeogo; Jean-Francois Trape; Guy Vernet
Journal:  Vaccine       Date:  2012-12-27       Impact factor: 3.641

Review 6.  Maternal immunisation to improve the health of HIV-exposed infants.

Authors:  Angela M Bengtson; Alan M Sanfilippo; Brenna L Hughes; David A Savitz
Journal:  Lancet Infect Dis       Date:  2018-12-07       Impact factor: 25.071

7.  Seasonality of meningitis in Africa and climate forcing: aerosols stand out.

Authors:  L Agier; A Deroubaix; N Martiny; P Yaka; A Djibo; H Broutin
Journal:  J R Soc Interface       Date:  2012-12-05       Impact factor: 4.118

8.  Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.

Authors:  Zhigang Jin; Chiayung Chu; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 9.  A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa.

Authors:  Yohannes W Woldeamanuel; Belaineh Girma
Journal:  J Neurol       Date:  2013-08-21       Impact factor: 4.849

10.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.